// App-Quantinova.ai

SAT0024 (2018) : Il-36 axis is an emerging therapeutic target in psoriatic arthritis synovial tissue

Researchers

Presenter

  • M.-A. Boutet

Principal Investigators

  • A. Nerviani

  • G. Lliso-Ribera

  • K. Goldmann

  • M. Lewis

  • C. Pitzalis

Medical Centers

  • Centre for Experimental Medicine and Rheumatology Queen Mary London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • Peripheral blood mononuclear cell

  • Interleukin-36

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved